- Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.. The Lancet. Oncology. 17:1558-1568. 2016
- A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off.. Head and neck pathology. 10:405-413. 2016
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma. 2015
- Ubiquitin-specific peptidase 20 regulates Rad17 stability, checkpoint kinase 1 phosphorylation and DNA repair by homologous recombination. 2014
- The role of the human psoralen 4 (hPso4) protein complex in replication stress and homologous recombination. 2014
- A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers.. Translational oncology. :-. 2014
- A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma.. Cancers. 5:418-429. 2013
- Cytotoxic activity of the titanium alkoxide (OPy)(2)Ti(4AP)(2) against cancer colony forming cells.. Investigational new drugs. 30:114-120. 2012
- Targeting the Transposase Domain of the DNA Repair Component Metnase to Enhance Chemotherapy.. Cancer research. 72:6200-6208. 2012
- Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining.. Proceedings of the National Academy of Sciences of the United States of America. 108:540-545.
- Metnase/SETMAR: a domesticated primate transposase that enhances DNA repair, replication, and decatenation.. Genetica. 138:559-566.
- Synthetic lethality: exploiting the addiction of cancer to DNA repair.. Blood. 117:6074-6082.
- The Role of PCNA Posttranslational Modifications in Translesion Synthesis.. Journal of nucleic acids. 2010:-.